Feminizing hormone therapy in a Canadian cohort of transgender women with and without HIV.
Ian ArmstrongAshley Lacombe-DuncanMostafa ShokoohiYasmeen PersadAlice TsengRaymond FungAngela UnderhillPierre CôtéNimâ MachoufAdrien SaucierBrenda VarrianoMonica BrundageReilly JonesThea WeisdorfJohn GoodhewJohn MacLeodMona LoutfyPublished in: Antiviral therapy (2023)
In this cohort, trans women with HIV were prescribed FHT less often than trans women with negative or unknown HIV status. There was no difference in serum estradiol or testosterone levels of trans women on FHT regardless of HIV status, providing reassurance regarding potential drug-drug interactions between FHT and ART.
Keyphrases
- antiretroviral therapy
- hiv testing
- hiv infected
- hiv positive
- human immunodeficiency virus
- men who have sex with men
- hepatitis c virus
- hiv aids
- south africa
- stem cells
- skeletal muscle
- adipose tissue
- polycystic ovary syndrome
- replacement therapy
- insulin resistance
- pregnancy outcomes
- electronic health record
- adverse drug
- estrogen receptor